Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 661301Generated: November 1, 2026

m-Chloroperbenzoic acid → {3-(3-Ethoxy-1,2,4-oxadiazol-5-yl)-5-[4-(2,2,2-trifluoroethyl)phenyl]piperidin-1-yl}(1-oxidothio-morpholin-4-yl)methanone

https://huagongshe.com/reaction/661301

Reaction equation

Participants

RoleNameHCIDCharge
Reactantm-Chloroperbenzoic acidHCID 70297—
Reactant{3-(3-Ethoxy-1,2,4-oxadiazol-5-yl)-5-[4-(2,2,2-trifluoroethyl)phenyl]piperidin-1-yl}-(thiomorpholin-4-yl)methanoneHCID 58116557—
Product{3-(3-Ethoxy-1,2,4-oxadiazol-5-yl)-5-[4-(2,2,2-trifluoroethyl)phenyl]piperidin-1-yl}(1-oxidothio-morpholin-4-yl)methanoneHCID 5811653244.1%

Reaction Steps

129 mg (0.266 mmol) of the compound from Example 64 were reacted according to General Method 2 with 82.7 mg (0.240 mmol) of meta-chloroperbenzoic acid. Enantiomer separation of 132 mg of the racemate according to Method 8D gave 51.0 mg of the title compound from Example 65 (enantiomer 1) and 53.0 mg of the title compound from Example 66 (enantiomer 2).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08084469B2
Source datasetuspto-grants-2011_12
ORD IDord-31ad2a4f90264558a8cb24718a487c52
Source noteuspto-grants-2011_12